City of Hope researchers developed a combination therapy to treat late-stage type 1 diabetes that appears to offer a potential lifetime cure for the disease without toxic side effects. The laboratory study is published in the May 9 edition of Science Translational Medicine.

City of Hope researchers have shown how leukemia stem cells hijack the bone marrow where they live, helping them to proliferate, potentially outlast powerful therapy and return to cause cancer.

The grant extends the NCI’s recognition of City of Hope’s Specialized Program of Research Excellence for lymphoma (Lymphoma SPORE), which the NCI first funded in 2004.

Twenty-five City of Hope physicians are featured in the recently published seventh edition of the book, “America’s Top Doctors for Cancer.” The book is a consumer guide to the nation’s top cancer specialists. It includes profiles of more than 2,000 doctors in 49 cancer specialties and subspecialties.

City of Hope researchers have discovered that the investigational drug brivanib helps to reset that microenvironment — and make anti-cancer immunotherapies more effective. Brivanib targets a tumor’s ability to build new blood vessels, cutting off its supply line.